Tumor heterogeneity as a rationale for a multi-epitope approach in an autologous renal cell cancer tumor vaccine

Tumor heterogeneity as a rationale for a multi-epitope approach in an autologous renal cell cancer tumor vaccine

Stefan Wittke,1 Susann Baxmann,2 Dirk Fahlenkamp,3 Stephan T Kiessig2 1University of Applied Sciences Bremerhaven, Faculty of Biotechnology Bremerhaven, 2Ruhr-Plasma-Centre GmbH, Bochum, 3Department of Urology, Zeisigwald Bethanien Hospital, Chemnitz, Germany Purpose: An autologous tumor vaccine a...

Full description

Bibliographic Details
Main Authors: Wittke S, Baxmann S, Fahlenkamp D, Kiessig ST
Format: Article
Language:English
Published: Dove Medical Press 2016-01-01
Series:OncoTargets and Therapy
Subjects:
Renal cell carcinoma
kidney cancer
tumor associated antigens
tumor marker
ELISA
Western Blot
immunotherapy
therapeutic vaccine
potency testing
Topological proteomics
Online Access:https://www.dovepress.com/tumor-heterogeneity-as-a-rationale-for-a-multi-epitope-approach-in-an--peer-reviewed-article-OTT

Internet

https://www.dovepress.com/tumor-heterogeneity-as-a-rationale-for-a-multi-epitope-approach-in-an--peer-reviewed-article-OTT

Similar Items